Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells

Human Gene Therapy

Volumn 14, Issue 6, 2003, Pages 509-519

  Leurs, Cordula ^a   Jansen, Michael ^b,c   Pollok, Karen E ^c   Heinkelein, Martin ^d   Schmidt, Manfred ^e   Wissler, Manuela ^e,f   Lindemann, Dirk ^d   Von Kalle, Christof ^b   Rethwilm, Axel ^d   Williams, David A ^b,c   Hanenberg, Helmut ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS GLYCOPROTEIN G; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ARTICLE; BONE MARROW CELL; CELL STIMULATION; CLONAL VARIATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIABETES MELLITUS; EXPRESSION VECTOR; FOAMY VIRUS VECTOR; GENE CONSTRUCT; GENE THERAPY; GIBBON LEUKEMIA VIRUS; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MURINE LEUKEMIA VIRUS; OBESITY; PATHOGENESIS; PSEUDOTYPING; RECOMBINANT RETROVIRUS VECTOR; SAFETY; SCID MOUSE; SIGNAL TRANSDUCTION; SPUMA VIRUS; TARGET CELL; UMBILICAL CORD BLOOD; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS RECOMBINANT; VIRUS TYPING; WILD TYPE;

ANIMALS; ANTIGENS, CD34; CELL LINE; FETAL BLOOD; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIV-1; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; RETROVIRIDAE; SPUMAVIRUS; TRANSDUCTION, GENETIC;

ALOCASIA MACRORRHIZOS; ANIMALIA; GIBBON APE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; HYLOBATES SP.; LENTIVIRUS; MAMMALIA; MURINAE; MURINE LEUKEMIA VIRUS; SPUMAVIRUS; UNIDENTIFIED RETROVIRUS; VECTORS; VESICULAR STOMATITIS VIRUS;

EID: 0344089002     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403764539305     Document Type: Article

References (61)

1. ABONOUR, R., WILLIAMS, D.A., EINHORN, L., HALL, K.M., CHEN, J., COFFMAN, J., TRAYCOFF, C.M., BANK, A., KATO, I., WARD, M., WILLIAMS, S.D., HROMAS, R., ROBERTSON, M.J., SMITH, F.O., WOO, D., MILLS, B., SROUR, E.F., and CORNETTA, K. (2000). Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat. Med. 6, 652-658.
2. AIUTI, A., SLAVIN, S., AKER, M., FICARA, F., DEOLA, S., MORTELLARO, A., MORECKI, S., ANDOLFI, G., TABUCCHI, A., CARLUCCI, F., MARINELLO, E., CATTANEO, F., VAI, S., SERVIDA, P., MINIERO, R., RONCAROLO, M.G., and BORDIGNON, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
3. ALI, M., TAYLOR, G.P., PITMAN, R.J., PARKER, D., RETHWILM, A., CHEINGSONG-POPOV, R., WEBER, J.N., BIENIASZ, P.D., BRADLEY, J., and MCCLURE, M.O. (1996). No evidence of antibody to human foamy virus in widespread human populations. AIDS Res. Hum. Retroviruses 12, 1473-1483.
4. BAHNSON, A.B., DUNIGAN, J.T., BAYSAL, B.E., MOHNEY, T., ATCHISON, R.W., NIMGAONKAR, M.T., BALL, E.D., and BARRANGER, J.A. (1995). Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods 54, 131.
5. BAUM, C., HEGEWISCH-BECKER, S., ECKERT, H.G., STOCKING, C., and OSTERTAG, W. (1995). Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69, 7541-7547.
6. BIENIASZ, P.D., WEISS, R.A., and McCLURE, M.O. (1995). Cell cycle dependence of foamy retrovirus infection. J. Virol. 69, 7295-7299.
7. BRENNER, M.K. (1996). Gene transfer into hematopoietic cells. N. Engl. J. Med. 335, 337-339.
8. CAVAZZANA-CALVO, M., HACEIN-BEY, S., DE SAINT BASILE, G., GROSS, F., YVON, E., NUSBAUM, P., SELZ, F., HUE, C., CERTAIN, S., CASANOVA, J.L., BOUSSO, P., DEIST, F.L., and FISCHER, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
9. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 89, 446-456.
10. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92, 2641-2649.
11. + cord blood cells. Blood 93, 1097-1105.
12. - bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol. Ther. 1, 566-573.
13. HACEIN-BEY-ABINA, S., LE DEIST, F., CARLIER, F., BOUNEAUD, C., HUE, C., DE VILLARTAY, J.P., THRASHER, A.J., WULFFRAAT, N., SORENSEN, R., DUPUIS-GIROD, S., FISCHER, A., DAVIES, E.G., KUIS, W., LEIVA, L., and CAVAZZANA-CALVO, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193.
14. HANENBERG, H., XIAO, X.L., DILLOO, D., HASHINO, K., KATO, I., and WILLIAMS, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2, 876-882.
15. + hematopoietic cells. Hum. Gene Ther. 8, 2193-2206.
16. HEINKELEIN, M., PIETSCHMANN, T., JARMY, G., DRESSLER, M., IMRICH, H., THUROW, J., LINDEMANN, D., BOCK, M., MOEBES, A., ROY, J., HERCHENRÖDER, O., and RETHWILM, A. (2000). Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J. 19, 3436-3445.
17. HENEINE, W., SWITZER, W.M., SANDSTROM, P., BROWN, J., VEDAPURI, S., SCHABLE, C.A., KHAN, A.S., LERCHE, N.W., SCHWEIZER, M., NEUMANN-HAEFELIN, D., CHAPMAN, L.E., and FOLKS, T.M. (1998). Identification of a human population infected with simian foamy viruses. Nat. Med. 4, 403-407.
18. HERCHENRÖDER, O., RENNE, R., LONCAR, D., COBB, E.K., MURTHY, K.K., SCHNEIDER, J., MERGIA, A., and LUCIW, P.A. (1994). Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV). Virology 201, 187-199.
19. HIRSCHHORN, R., YANG, D.R., PUCK, J.M., HUIE, M.L., JIANG, C.-K., and KURLANDSKY, L.E. (1996). Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat. Genet. 13, 290-295.
20. HOOKS, J.J., and GIBBS, C.J., Jr. (1975). The foamy viruses. Bacteriol. Rev. 39, 169-185.
21. HORWITZ, M.E., MALECH, H.L., ANDERSON, S.M., GIRARD, L.J., BODINE, D.M., and ORLIC, D. (1999). Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retro-virus receptor mRNA. Exp. Hematol. 27, 1160-1167.
22. JARMY, G., HEINKELEIN, M., WEISSBRICH, B., JASSOY, C., and RETHWILM, A. (2001). Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system. J. Med. Virol. 64, 223-231.
23. JOSEPHSON, N.C., VASSILOPOULOS, G., TROBRIDGE, G.D., PRIESTLEY, G.V., WOOD, B.L., PAPAYANNOPOULOU, T., and RUSSELL, D.W. (2002). Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc. Natl. Acad. Sci. U.S.A. 99, 8295-8300.
24. LAROCHELLE, A., VORMOOR, J., HANENBERG, H., WANG, J.C.Y., BHATIA, M., LAPIDOT, T., MORITZ, T., MURDOCH, B., XIAO, X.L., KATO, I., WILLIAMS, D.A., and DICK, J.E. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat. Med. 2, 1329-1337.
25. LINDEMANN, D., and GOEPFERT, P.A. (2002). The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. (in press).
26. LINDEMANN, D., and RETHWILM, A. (1998). Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 72, 4088-4094.
27. LINDEMANN, D., BOCK, M., SCHWEIZER, M., and RETHWILM, A. (1997). Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71, 4815-4820.
28. LINIAL, M. (2000). Why aren't foamy viruses pathogenic? Trends Microbiol. 8, 284-289.
29. MEIERING, C.D., and LINIAL, M.L. (2001). Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14, 165-176.
30. MERGIA, A., and HEINKELEIN, M. (2003). Foamy virus vectors. Curr. Top. Microbiol. Immunol. (in press).
31. MERGIA, A., CHARI, S., KOLSON, D.L., GOODENOW, M.M., and CICCARONE, T. (2001). The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Virology 280, 243-252.
32. + cells that mediate long-term engraftment of NOD/SCID mice with HIV vectors. Science 283, 682-686.
33. MOEBES, A., ENSSLE, J., BIENIASZ, P.D., HEINKELEIN, M., LINDEMANN, D., BOCK, M., McCLURE, M.O., and RETHWILM, A. (1997). Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71, 7305-7311.
34. NALDINI, L., BLÖMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M, and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
35. ORLIC, D., GIRARD, L.J., JORDAN, C.T., ANDERSON, S.M., CLINE, A.P., and BODINE, D.M. (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. U.S.A. 93, 11097-11102.
36. ORLIC, D., GIRARD, L.J., ANDERSON, S.M., PYLE, L.C., YODER, M.C., BROXMEYER, H.E., and BODINE, D.M. (1998). Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors. Blood 91, 3247-3254.
37. ORY, D.S., NEUGEBOREN, B.A., and MULLIGAN, R.C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U.S.A. 93, 11400-11406.
38. PIETSCHMANN, T., HEINKELEIN, M., HELDMANN, M., ZENTGRAF, H., RETHWILM, A., and LINDEMANN, D. (1999). Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73, 2613-2621.
39. PIETSCHMANN T., ZENTGRAF, H., RETHWILM, A., and LINDEMANN, D. (2000). An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 74, 4474-4482.
40. POLLOK, K.E., VAN DER LOO, J.C.M., COOPER, R.J., HARTWELL, J.R., MILES, K.R., BREESE, R., WILLIAMS, E.P., MONTEL, A., SESHADRI, R., HANENBERG, H., and WILLIAMS, D.A. (2001). Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and G-CSF mobilized peripheral blood. Hum. Gene Ther. 12, 2095-2108.
41. REEVES, L., SMUCKER, P., and CORNETTA, K. (2000). Packaging cell line characteristics and optimizing retroviral vector titer: The National Gene Vector Laboratory experience. Hum. Gene Ther. 11, 2093-2103.
42. REISER, J., HARMISON, G., KLUEPFEL-STAHL, S., BRADY, R.O., KARLSSON, S., and SCHUBERT, M. (1996). Transduction of non-dividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. U.S.A. 93, 15266-15271.
43. RETHWILM, A. (1995). Regulation of foamy virus gene expression. Curr. Top. Microbiol. Immunol. 193, 1-24.
44. RETHWILM, A., and MCCLURE, M.O. (2003). Foamy virus replication strategy. Curr. Top. Microbiol. Immunol. (in press).
45. RUSSELL, D.W., and MILLER, A.D. (1996). Foamy virus vectors. J. Virol. 70, 217-222.
46. SAIB, A., PUVION-DUTILLEUL, F., SCHMID, M., PERIES, J., and DE THE, H. (1997). Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J. Virol. 71, 1155-1161.
47. SANDSTROM, P.A., PHAN, K.O., SWITZER, W.M., FREDEKING, T., CHAPMAN, L., HENEINE, W., and FOLKS, T.M. (2000). Simian foamy virus infection among zoo keepers. Lancet 355, 551-552.
48. + NOD/SCID-repopulating cells. Blood 99, 709-712.
49. SCHILZ, A.J., SCHIEDLMEIER, B., KUHLCKE, K., FRUEHAUF, S., LINDEMANN, C., ZELLER, W.J., GREZ, M., FAUSER, A.A., BAUM, C., and ECKERT, H.G. (2000). MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol. Ther. 2, 609-618.
50. SCHMIDT, M., ZICKLER, P., HOFFMAN, G., HAAS, S., WISSLER, M., MUESSIG, A., TISDALE, J.F., ANDREWS, R.G., WU, T., KIEM, H.-P., DUNBAR, C.E., and KALLE, C.V. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100, 2737-2743.
51. SCHWEIZER, M., TUREK, R., HAHN, H., SCHLIEPHAKE, A., NETZER, K.O., EDER, G., REINHARDT, M., RETHWILM.A., and NEUMANN-HAEFELIN, D. (1995). Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses 11, 161-170.
52. SCHWEIZER, M., FALCONE, V., GANGE, J., TUREK, R., and NEUMANN-HAEFELIN, D. (1997). Simian foamy virus isolated from an accidentally infected human individual. J. Virol. 71, 4821-4824.
53. SPARACIO, S., PFEIFFER, T., SCHAAL, H., and BOSCH, V. (2001). Generation of a flexible line with regulatable, high-level expression of HIV-Gag/Pol particles capable of packaging HIV-derived vectors. Mol. Ther. 3, 602-612.
54. STEPHAN, V., WAHN, V., LE DEIST, F., DIRKSEN, U., BROKER, B., MÜLLER-FLECKENSTEIN, I., HORNEFF, G., SCHROTEN, H., FISCHER, A., and DE SAINT BASILE, G. (1996). Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335, 1563-1567.
55. STITZ, J., BUCHHOLZ, C.J., ENGELSTADTER, M., UCKERT, W., BLOEMER, U., SCHMITT, I., and CICHUTEK, K. (2000). Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273, 16-20.
56. VON LAER, D., LINDEMANN, D., ROSCHER, S., HERWIG, U., FRIEL, J., and HERCHENRÖDER, O. (2001). Low-level expression of functional foamy virus receptor on hematopoietic progenitor cells. Virology 288, 139-144.
57. WILLIAMS, D.A., NIENHUIS, A.W., HAWLEY, R.G., and SMITH, F.O. (2000). Gene therapy 2000. In: Hematology 2000. Schechter, G., ed. American Society of Hematology Education Program. (W.B. Saunders, Philadelphia), pp. 376-393.
58. WOODS, N.B., FAHLMAN, C., MIKKOLA, H., HAMAGUCHI, I., OLSSON, K., ZUFFEREY, R., JACOBSEN, S.E., TRONO, D., and KARLSSON, S. (2000). Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Blood 96, 3725-3733.
59. XU, K., MA, H., MCCOWN, T.J., VERMA, I.M., and KAFRI, T. (2001). Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol. Ther. 3, 97-104.
60. YU, S.F., SULLIVAN, M.D., and LINIAL, M.L. (1999). Evidence that the human foamy virus genome is DNA. J. Virol. 73, 1565-1572.
61. + NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector. Virology 302, 229-235.